Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study
PLOS Neglected Tropical Diseases · 21.03.2024 · 18 (3) · e0012059
DOI: 10.1371/journal.pntd.0012059 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 21.03.2024. Verfasst von Luís-Jorge Amaral und 10 weiteren Autor:innen. Beteiligte Einrichtung: Global Health Institute, University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Onchocerciasis, Epilepsy, Nodding Syndrome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, La Caixa Foundation, Research Foundation – Flanders.
Abstract (Originalsprache)
Objectives
The potential impact of cumulative community-directed treatment with ivermectin (CDTI) on epilepsy epidemiology in Mvolo County, South Sudan, an onchocerciasis-endemic area with high epilepsy prevalence, was investigated. Annual CDTI was introduced in 2002 in Mvolo, with interruptions in 2016 and 2020.
Methods
Comprehensive house-to-house surveys in Mvolo (June 2020 and 2022) identified cases of epilepsy, including probable nodding syndrome (pNS). Community workers screened households in selected sites for suspected epilepsy, and medical doctors confirmed the diagnosis and determined the year of seizure onset. The incidence of epilepsy, including pNS, was analysed using 95% confidence intervals (CIs). Data on ivermectin intake and onchocerciasis-associated manifestations (itching and blindness) were collected.
Results
The surveys covered 15,755 (2020) and 15,092 (2022) individuals, identifying 809 (5.2%, 95% CI: 4.8–5.5%) and 672 (4.5%, 95% CI: 4.1–4.8%) epilepsy cases, respectively. Each survey reported that a third of the surveyed population experienced skin itching, and 3% were blind. Epilepsy incidence per 100,000 person-years gradually declined, from 326.5 (95% CI: 266.8–399.1) in 2013–2015 to 96.6 (95% CI: 65.5–141.7) in 2019–2021. Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). Coverage of CDTI was suboptimal, reaching only 64.0% of participants in 2019 and falling to 24.1% in 2021 following an interruption in 2020 due to COVID-19 restrictions. Additionally, while 99.4% of cases had active epilepsy in 2022, less than a quarter of these had access to antiseizure medication.
Conclusions
The observed decrease in epilepsy incidence despite suboptimal CDTI coverage highlights the potential impact of onchocerciasis control efforts and underscores the need to strengthen these efforts in Mvolo County and across South Sudan. As a proactive measure, Mvolo and neighbouring counties are transitioning to biannual CDTI. Furthermore, the substantial epilepsy treatment gap in Mvolo should be addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Global Health Institute, University of Antwerp, Antwerp, Belgium.
- Amref Health Africa, South Sudan.
- Amref Health Africa Headquarters, Nairobi, Kenya.
- Access for Humanity, Juba, South Sudan.
- School of Public Health, University of Juba, Juba, South Sudan.
- Neglected Tropical Diseases Unit, Ministry of Health, Juba, South Sudan.
ORCID-Profile: Luís-Jorge Amaral
Förderung
- European Research Council
- La Caixa Foundation
- Research Foundation – Flanders
- Research for Health in Humanitarian Crises
- H2020 European Research Council
- 'la Caixa' Foundation
Zitieren
APA
Amaral, L. J., Jada, S. R., Ndjanfa, A. K., Carter, J. Y., Abd-Elfarag, G., Okaro, S., Logora, M. Y., Bol, Y. Y., Lakwo, T., Fodjo, J. N. S., & Colebunders, R. (2024). Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study. PLOS Neglected Tropical Diseases, 18(3), e0012059. https://doi.org/10.1371/journal.pntd.0012059
Vancouver
Amaral LJ, Jada SR, Ndjanfa AK, Carter JY, Abd-Elfarag G, Okaro S, et al. Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study. PLOS Neglected Tropical Diseases. 2024;18(3):e0012059. doi:10.1371/journal.pntd.0012059
BibTeX
@article{Amaral2024,
author = {Amaral, Luís-Jorge and Jada, Stephen Raimon and Ndjanfa, Aimee Kemayou and Carter, Jane Y and Abd-Elfarag, Gasim and Okaro, Samuel and Logora, Makoy Yibi and Bol, Yak Yak and Lakwo, Thomson and Fodjo, Joseph N Siewe and Colebunders, Robert},
title = {Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
volume = {18},
number = {3},
pages = {e0012059},
doi = {10.1371/journal.pntd.0012059}
}
EUVIMED